Sun Pharmaceutical Industries Ltd. Stock Forecast Outlook:Negative Period (n+30) 24 Jun 2020


Stock Forecast


As of Wed Jun 24 2020 12:36:11 GMT+0000 (Coordinated Universal Time) shares of Sun Pharmaceutical Industries Ltd. -1.18 percentage change in price since the previous day's close. Around 4849544 of 0 changed hand on the market. The Stock opened at 502 with high and low of 487.45 and 503.4 respectively. The price/earnings ratio is: 31.49 and earning per share is 15.69. The stock quoted a 52 week high and low of 312 and 512.7 respectively.

BOSTON (AI Forecast Terminal) Wed, Jun 24, '20 AI Forecast today took the forecast actions: In the context of stock price realization of Sun Pharmaceutical Industries Ltd. is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+30) for Sun Pharmaceutical Industries Ltd. as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of Sun Pharmaceutical Industries Ltd. as below:

Sun Pharmaceutical Industries Ltd. Credit Rating Overview


We rerate Sun Pharmaceutical Industries Ltd. because of the risk or unstable nature of the firm's mix of business, some aspect of the firm's market position, customer confidence sensitivity, or expected revenue stability are materially weaker than average, or represent substantial risk beyond risks captured in the anchor. We use econometric methods for period (n+30) simulate with Ichimoku Cloud (IKH) Multiple Regression. Reference code is: 1566. Beta DRL value REG 23 Rational Demand Factor LD 4305.365400000001. The EBITDA declines companies would have to withstand and still have defined sources cover defined uses are as follows for each liquidity descriptor: Adequate: Positive A-B, even if forecasted EBITDA declines by 30%.Weak: A/B or A-B reflecting a material deficit over the next 12 months. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for Sun Pharmaceutical Industries Ltd. as below:
Frequently Asked QuestionsQ: What is Sun Pharmaceutical Industries Ltd. stock symbol?
A: Sun Pharmaceutical Industries Ltd. stock referred as NSE:SUNPHARMA
Q: What is Sun Pharmaceutical Industries Ltd. stock price?
A: On share of Sun Pharmaceutical Industries Ltd. stock can currently be purchased for approximately 494.55
Q: Do analysts recommend investors buy shares of Sun Pharmaceutical Industries Ltd. ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for Sun Pharmaceutical Industries Ltd. at daily forecast section
Q: What is the earning per share of Sun Pharmaceutical Industries Ltd. ?
A: The earning per share of Sun Pharmaceutical Industries Ltd. is 15.69
Q: What is the market capitalization of Sun Pharmaceutical Industries Ltd. ?
A: The market capitalization of Sun Pharmaceutical Industries Ltd. is 1186470663000
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com